[Multilevel botulinum toxin treatment in severe spastic forms of cerebral palsy (GMFCS IV-V)].

A L Kurenkov O A Klochkova L M Kuzenkova B I Bursagova Kh M Karimova

Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2021)

The majority of patients with GMFCS IV-V required multilevel BTA injections in high dosages, especially in young age. Described selection of target muscles and dosages of AboA could be taken into account as a practical experience and reference for the BTA therapy in GMFCS IV-V patients.

Keyphrases

cerebral palsy
botulinum toxin
end stage renal disease
newly diagnosed
ejection fraction
peritoneal dialysis
prognostic factors
ultrasound guided
platelet rich plasma
bone marrow
cell therapy
drug induced